- Home
- ADTX vs UPXI Comparison
ADTX vs UPXI Comparison
Compare ADTX & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- UPXI
- Stock Information
- Founded
- ADTX 2017
- UPXI 2018
- Country
- ADTX United States
- UPXI United States
- Employees
- ADTX N/A
- UPXI N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- ADTX Health Care
- UPXI Health Care
- Exchange
- ADTX Nasdaq
- UPXI Nasdaq
- Market Cap
- ADTX 5.3M
- UPXI 4.6M
- IPO Year
- ADTX 2020
- UPXI 2021
- Fundamental
- Price
- ADTX $2.50
- UPXI $2.30
- Analyst Decision
- ADTX
- UPXI
- Analyst Count
- ADTX 0
- UPXI 0
- Target Price
- ADTX N/A
- UPXI N/A
- AVG Volume (30 Days)
- ADTX 663.2K
- UPXI 61.9K
- Earning Date
- ADTX 05-19-2025
- UPXI 05-07-2025
- Dividend Yield
- ADTX N/A
- UPXI N/A
- EPS Growth
- ADTX N/A
- UPXI N/A
- EPS
- ADTX N/A
- UPXI N/A
- Revenue
- ADTX $133,985.00
- UPXI $18,625,089.00
- Revenue This Year
- ADTX $15,768.94
- UPXI $299.03
- Revenue Next Year
- ADTX N/A
- UPXI N/A
- P/E Ratio
- ADTX N/A
- UPXI N/A
- Revenue Growth
- ADTX N/A
- UPXI 4.75
- 52 Week Low
- ADTX $2.04
- UPXI $1.90
- 52 Week High
- ADTX $27,200.00
- UPXI $15.91
- Technical
- Relative Strength Index (RSI)
- ADTX 30.71
- UPXI 45.17
- Support Level
- ADTX $2.53
- UPXI $1.90
- Resistance Level
- ADTX $3.50
- UPXI $2.96
- Average True Range (ATR)
- ADTX 0.64
- UPXI 0.30
- MACD
- ADTX 0.41
- UPXI 0.07
- Stochastic Oscillator
- ADTX 12.34
- UPXI 37.20
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.